| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -9.6% |
| Cost of Revenue | $7.8M | +8.5% |
| Gross Profit | $2.2M | -42.9% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $2.4M | +27.2% |
| Operating Income | -$6.7M | +18.6% |
| Interest Expense | $2.6M | +72.2% |
| Pre-tax Income | -$4.1M | +49.6% |
| Income Tax | $0 | — |
| Net Income | -$4.1M | +49.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $518K | +2583.0% |
| Accounts Receivable | $102K | -38.2% |
| Current Assets | $742K | +103.7% |
| Total Assets | $10.7M | -16.8% |
| Current Liabilities | $33.5M | +2.0% |
| Long-term Debt | $218K | -74.1% |
| Total Liabilities | $36.7M | +0.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$995K | -103.3% |
| Investing Cash Flow | $324K | +164.7% |
| Financing Cash Flow | $1.2M | +43.1% |
| Stockholders' Equity |
| -$31.1M |
| -9.4% |